A Korean study proved its value only in normoalbuminuric diabetic patients.[32] Urinary kidney injury molecule 1 (KIM-1) was also evaluated for predicting CKD progression.[33–35] Bhavsar et al[33] and Nielsen et al[35] could not demonstrate a benefit using KIM-1 for risk stratification. The gene discussed is HAVCR1; the disease is chronic kidney disease.